Third, pancreatic cancer is known to be desmoplastic with a high concentration of cancer-associated fibroblasts inducing an immunosuppressive TME, limiting the potential for immunotherapy (138), as supported by a lack of efficacy of anti-PD-L1 in pancreatic cancer (139). This evidence concerns the gene CD274 and familial pancreatic carcinoma.